April 2015
Innovation Prize 2015: Make the right moves in your project development

      The Innovation Prize is an opportunity catalyst ! Since the begining of this event, 8 finalists start-ups signed a licence with a pharmaceutical company . Altogether, and thanks to the visibility offe red by the Prize, more than 50% of those start-ups raised fund for their project! Participate in the 6th edition of the Innovation Days ! Innovation Prize 2015 Team Innovation

03

Avr
2015
Commentaires fermés sur Innovation Prize 2015: Make the right moves in your project development
La biotech vise un marché de plus de 300 millions d’euros

Nous venons de rencontrer le directeur financier d AB Science, Laurent Guy, dans le cadre des Rencontres PEA PME organisées par Portzamparc au Palais Brongniart. AB Science, qui emploie 120...

01

Avr
2015
Commentaires fermés sur La biotech vise un marché de plus de 300 millions d’euros

Les biotechnologies ont vécu une journée d’euphorie, lundi, avec la vente à prix d’or de deux d’entre elles. L’américain Auspex s’est...

01

Avr
2015
Commentaires fermés sur Quand les biotechs affolent la bourse
March 2015
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion

Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system. Teva, the world's largest maker of generic drugs, will offer $101 per share in cash, representing a premium of 42.4 percent to Auspex's Friday closing price, the companies said on Monday.

31

Mar
2015
Commentaires fermés sur Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion

mars 2015

Page 30 of 35« First...1020...2829303132...Last »